Seer said it will support the PRECISE-SG100K initiative by profiling plasma proteomes for roughly 10,000 participants using its Proteograph platform. The workflow will be combined with data from the same cohort generated through Thermo Fisher Scientific’s Olink Reveal and Orbitrap Astral mass spectrometers, with the aim of building a large multi-omics resource. The initiative is part of a broader Singapore population effort designed to integrate genomic, proteomic, lifestyle, imaging and other health data across a multi-ancestry Asian cohort. PRECISE-SG100K is described as a landmark population dataset intended to support disease risk discovery and potentially treatment-response research. Seer and Thermo Fisher previously announced co-marketing and sales alignment for Proteograph alongside Orbitrap Astral, reflecting growing competition in population-scale, high-throughput proteomics.